3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
3
Various Advanced Cancer
2
Stomach Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urothelial Cancer
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Microsatellite Unstable Colorectal Cancer
1
Mesothelioma
1
Lymphoma
1
Lung Neoplasms
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced or Metastatic Solid Tumors
1
Interventions
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
belzutifan
1
Lutetium-177
1
Lutetium
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Paraganglioma
×
Nivolumab
×
Clear all
No trials found.